As BRAF mutation has been previously reported to be associated with a particularly poor survival in cases with microsatellite stable (MSS) tumours [8,15,30,31], we also examined whether the prognostic value of BRAF mutation differs by MSI status, overall and stratified for sex. The gene discussed is BRAF; the disease is neoplasm.